{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:59:30Z","timestamp":1791280770084,"version":"4.1.0"},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T00:00:00Z","timestamp":1339718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Identifying the best gene expression pattern associated with low\u2010risk disease in patients with newly diagnosed multiple myeloma (<jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content>) is important to direct clinical treatments. The <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> Survival Index14 (<jats:styled-content style=\"fixed-case\">MMSI<\/jats:styled-content>14) was developed from <jats:styled-content style=\"fixed-case\">GEP<\/jats:styled-content> data sets of 22 normal plasma cells (<jats:styled-content style=\"fixed-case\">NPC<\/jats:styled-content>), 5 <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> cell lines (<jats:styled-content style=\"fixed-case\">MMCL<\/jats:styled-content>), 44 monoclonal gammopathy of undetermined significance (<jats:styled-content style=\"fixed-case\">MGUS<\/jats:styled-content>), and 351 newly diagnosed <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> patients. <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>\/bioconductor and siggenes package were used to obtain heatmap, boxplot and histogram whose results were then analyzed by Kaplan\u2013Meier analysis. Fourteen genes associated with low\u2010risk disease in MM were identified. We validated the disease prognostic power of <jats:styled-content style=\"fixed-case\">MMSI<\/jats:styled-content>14 with an independent data set of other 214 newly diagnosed <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> patients and also compared our model with the 70\u2010gene, the 8\u2010subgroup, <jats:styled-content style=\"fixed-case\">IFM<\/jats:styled-content>15, and <jats:styled-content style=\"fixed-case\">HMCL<\/jats:styled-content>s7 models. Survival analysis showed that a low <jats:styled-content style=\"fixed-case\">MMSI<\/jats:styled-content>14 signature was associated with longer survival. Applying <jats:styled-content style=\"fixed-case\">MMSI<\/jats:styled-content>14 to independent data sets, we were able to classify 39% of patients as low\u2010risk, with a survival probability of more than 90% at 60\u00a0months. Multiple clinical parameters confirmed significant correlation between low\u2010 and high\u2010risk subgroups defined by <jats:styled-content style=\"fixed-case\">MMSI<\/jats:styled-content>14. Comparing previously published models to the same data sets the <jats:styled-content style=\"fixed-case\">MMSI<\/jats:styled-content>14 model retained the best prognostic value. We have developed a new gene model (<jats:styled-content style=\"fixed-case\">MMSI<\/jats:styled-content>14) for defining low\u2010risk, newly diagnosed <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content>. The multivariate comparative analysis confirmed that <jats:styled-content style=\"fixed-case\">MMSI<\/jats:styled-content>14 is the best available model to predict clinical outcome in <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> patients.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2012.01792.x","type":"journal-article","created":{"date-parts":[[2012,5,24]],"date-time":"2012-05-24T12:48:41Z","timestamp":1337863721000},"page":"28-36","source":"Crossref","is-referenced-by-count":11,"title":["Low\u2010risk identification in multiple myeloma using a new 14\u2010gene model"],"prefix":"10.1111","volume":"89","author":[{"given":"Tiehua","family":"Chen","sequence":"first","affiliation":[{"name":"Molecular Medicine Program University of Utah Salt Lake City Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Berno","sequence":"additional","affiliation":[{"name":"Myeloma Program University of Utah Salt Lake City Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Zangari","sequence":"additional","affiliation":[{"name":"Myeloma Program University of Utah Salt Lake City Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,6,15]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90739-0"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V67.5.1298.1298"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0522"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.9158"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-268862"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-04-1045"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.5878"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/454172a"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-013458"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-038430"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.13.8545"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.033456"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-255620"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature07064"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-037077"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1665"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2112"},{"key":"e_1_2_6_19_1","volume-title":"R: A Language and Enviroment for Statistical Computing. R Foundation for Statistical Computing","author":"R: Development Core Team","year":"2004"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2004-5-10-r80"},{"key":"e_1_2_6_21_1","volume-title":"Siggenes: Multiple Testing Using SAM and Efron's Empirical Bayes Approaches","author":"Schwender H","year":"2011"},{"key":"e_1_2_6_22_1","volume-title":"Coxphf: Cox Regression with Firth's Penalized Likelihood. R Package version 1.08","author":"Ploner M","year":"2011"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.1.80"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2012.01792.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2012.01792.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T08:22:33Z","timestamp":1698740553000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2012.01792.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,15]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1111\/j.1600-0609.2012.01792.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2012.01792.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,15]]}}}